Literature DB >> 28717986

Thrombolysis for stroke in Ireland: increasing access and maintaining safety in a challenging environment.

P McElwaine1,2,3, J McCormack4,5,6, C Brennan4,7, H Coetzee8, P Cotter8, R Doyle8, A Hickey9, F Horgan9, C Loughnane6, C Macey6, P Marsden7, D McCabe5,10, R Mulcahy11, I Noone8, E Shelley7, T Stapleton5, D Williams9, P Kelly4,8, J Harbison4,5,10.   

Abstract

BACKGROUND: In the setting of a national audit of acute stroke services, we examined the delivery of thrombolytic therapy for ischaemic stroke and whether current practice was achieving safe outcomes and consistent delivery for patients.
METHOD: Data obtained from the recent national stroke audit was compared against previous Irish audit, the most recent SSNAP UK stroke audit and the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) study.
RESULTS: Thrombolysis was provided in 27 acute hospitals throughout Ireland during the period assessed with 82% (22/27) providing 24/7 access, the remaining sites using redirect policies. Decision to thrombolyse was made by stroke trained consultants in 63% (17/27) of units, with general physicians and emergency medicine consultants covering the other units. Thrombolysis rate for non-haemorrhagic stroke was 11% (n = 80/742, CI 95% ±2.23) versus a 1% rate in the 2008 audit. Sites receiving patients through a redirect policy had the highest thrombolysis rate, an average of 24%. Nearly 30% of cases were thrombolysed on the weekend. Eighty-three percent of cases were managed in a stroke unit at some time during admission versus 54% of the national total cases. Thirty-seven percent of patients were ≥80 years old. The mortality rate was 11.3% versus the national mortality rate for non-thrombolysed ischaemic strokes of 10% (p > 0.5), and this is comparable to the SITS-MOST 2007 study 3-month mortality rate of 11.3% (p > 0.5).
CONCLUSION: Stroke thrombolysis is being effectively and safely provided in acute stroke services in Ireland despite regular involvement of non-specialist staff. There is still potential to improve thrombolysis rate.

Entities:  

Keywords:  Ischaemic stroke; National Audit; Patient safety; Service organisation; Stroke; Thrombolysis

Mesh:

Substances:

Year:  2017        PMID: 28717986     DOI: 10.1007/s11845-017-1661-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  13 in total

1.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

2.  Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.

Authors:  Craig S Anderson; Thompson Robinson; Richard I Lindley; Hisatomi Arima; Pablo M Lavados; Tsong-Hai Lee; Joseph P Broderick; Xiaoying Chen; Guofang Chen; Vijay K Sharma; Jong S Kim; Nguyen H Thang; Yongjun Cao; Mark W Parsons; Christopher Levi; Yining Huang; Verónica V Olavarría; Andrew M Demchuk; Philip M Bath; Geoffrey A Donnan; Sheila Martins; Octavio M Pontes-Neto; Federico Silva; Stefano Ricci; Christine Roffe; Jeyaraj Pandian; Laurent Billot; Mark Woodward; Qiang Li; Xia Wang; Jiguang Wang; John Chalmers
Journal:  N Engl J Med       Date:  2016-05-10       Impact factor: 91.245

3.  The national sentinel audit for stroke: a tool for raising standards of care.

Authors:  A G Rudd; P Irwin; Z Rutledge; D Lowe; D Wade; R Morris; M G Pearson
Journal:  J R Coll Physicians Lond       Date:  1999 Sep-Oct

4.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

5.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

6.  European Stroke Organisation recommendations to establish a stroke unit and stroke center.

Authors:  E Bernd Ringelstein; Angel Chamorro; Markku Kaste; Peter Langhorne; Didier Leys; Philippe Lyrer; Vincent Thijs; Lars Thomassen; Danilo Toni
Journal:  Stroke       Date:  2013-01-29       Impact factor: 7.914

7.  Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN.

Authors:  Nils Wahlgren; Tiago Moreira; Patrik Michel; Thorsten Steiner; Olav Jansen; Christophe Cognard; Heinrich P Mattle; Wim van Zwam; Staffan Holmin; Turgut Tatlisumak; Jesper Petersson; Valeria Caso; Werner Hacke; Mikael Mazighi; Marcel Arnold; Urs Fischer; Istvan Szikora; Laurent Pierot; Jens Fiehler; Jan Gralla; Franz Fazekas; Kennedy R Lees
Journal:  Int J Stroke       Date:  2016-01       Impact factor: 5.266

8.  Relative distributions: a novel method for examining trends between stroke onset and thrombolysis time.

Authors:  Peter McMeekin; John Wildman; Gary A Ford; Luke Vale; Christopher I Price
Journal:  Stroke       Date:  2015-04-09       Impact factor: 7.914

9.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

10.  Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?

Authors:  S Scherf; M Limburg; R Wimmers; I Middelkoop; H Lingsma
Journal:  BMC Neurol       Date:  2016-04-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.